In 2021, a group of scientists led by researchers at the University of North Carolina, Weill Cornell Medicine and NewYork-Presbyterian reported that the Moderna mRNA vaccine and a protein-based vaccine candidate containing a substance that enhances immune responses, known as an adjuvant, elicited durable neutralizing antibody responses to the virus that causes COVID-19 during infancy in preclinical research.
Karl Termini’s worktable holds pieces of glass, metal and rubber, from glass tubes and pipettes to flasks, funnels and columns.
From cell-sized robots to quantum computers to the manipulation of human genes, the Arts Unplugged: Science of the Very, Very Small event on March 9 will explore the nanoscale and quantum innovations shaping our future.